Research interests include Phytochemicals and Antioxidant Activities, Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism, and Cancer Treatment and Pharmacology.
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
Science Translational Medicine2021cited by 107position: middledoi
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy
Scientific Reports2021cited by 55position: middledoi
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
Breast Cancer Research2019cited by 67position: middledoi